I-124 PET/CT scan for diagnosing thyroid cancer
Part of Cancer, Hormones & metabolism clinical trials.
This trial tests whether a new type of scan (I-124 PET/CT) can better detect thyroid cancer compared to standard scans. It may help doctors decide on the best treatment, such as radiation therapy or surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 13 years or older.
- You have a type of thyroid cancer called differentiated or poorly differentiated thyroid cancer.
- You have either intermediate or high-risk thyroid cancer and are scheduled for I-131 treatment, or you have cancer that has spread and you are considering local treatments like surgery or radiation.
- You have had your entire thyroid gland removed (total thyroidectomy).
- You are willing to have a standard I-123 scan within 45 days after joining the study.
- You can understand and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special type of PET/CT scan (I-124) to see where thyroid cancer is in your body and how much radiation it would get from radioactive iodine therapy. It helps doctors plan treatment for people whose cancer may not respond to standard radioactive iodine or who are being considered for targeted medicines.
This trial tests how much radiation a specialized whole-body PET/CT scan delivers in patients with differentiated thyroid cancer. It may help doctors better plan treatment for cancer that persists, returns, or has spread—especially when radioactive iodine (RAI) may or may not work.
This trial tests a new type of PET scan (F-18 Tetrafluoroborate) to find thyroid cancer cells that don't show up on standard scans. It's for people who have had surgery and radioactive iodine therapy but still have signs of cancer in their blood tests.
This study tests a new type of PET scan to find thyroid cancer that has come back or spread. It compares two tracers to see which one better shows the cancer, which may help doctors choose the right treatment.
This trial tests a special PET scan (68Ga-FAPI) to see if it can better find thyroid cancer that has come back or spread after surgery. It may help your doctor decide on the best next steps for your care.
This study uses a special type of PET/CT scan (68Ga-FAPI) to see how well it finds cancer spread in lymph nodes before thyroid cancer surgery. It may help doctors plan your treatment more accurately.
Hear when a new Thyroid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.